Description
Parkinson et parkinsonismes
- Striatal (a-)symmetry reveals sex-specific autonomic vulnerabilities in early Parkinson's disease
NPJ Womens Health. 2026;4(1):2. doi: 10.1038/s44294-025-00121-8. Epub 2026 Jan 6.ABSTRACTAutonomic symptoms are common in Parkinson's disease and vary according to patterns of dopaminergic […]
- Primary care service utilisation pattern in dementia: a 10-year longitudinal population-based study
Age Ageing. 2026 Feb 1;55(2):afag016. doi: 10.1093/ageing/afag016.ABSTRACTBACKGROUND: Primary care services play a key role in dementia care, yet activity may vary between subtypes.OBJECTIVE: To […]
- Accelerating Medicines Partnership Parkinson's Disease Proteomics: A Comprehensive Resource for Advancing Parkinson's Disease Research
Mov Disord. 2026 Feb 5. doi: 10.1002/mds.70183. Online ahead of print.ABSTRACTBACKGROUND: Recent advances in proteomic profiling have enabled its use as a powerful approach in elucidating molecular […]
- Two novel iron metabolism-related genes identified as diagnostic indicators in substantia nigra of patients with Parkinson's disease
Parkinsonism Relat Disord. 2026 Jan 27;144:108218. doi: 10.1016/j.parkreldis.2026.108218. Online ahead of print.ABSTRACTINTRODUCTION: Parkinson's disease (PD) is a common neurodegenerative disease. […]
- Altered regional spontaneous brain activity in Parkinson's disease: a meta-analysis
Neurol Sci. 2026 Jan 24;47(2):194. doi: 10.1007/s10072-025-08637-2.ABSTRACTBACKGROUND AND PURPOSE: In recent years, resting-state functional magnetic resonance imaging (rs-fMRI) has been widely used […]
- ParkMAE: a cross-linguistic masked autoencoder framework for robust Parkinson's disease detection from speech
Sci Rep. 2025 Dec 10;16(1):783. doi: 10.1038/s41598-025-30251-7.ABSTRACTWe introduce ParkMAE, a robust multilingual speech foundation model and comprehensive benchmarking system for Parkinson's […]
- Integrative multi-omics and network-based machine learning for early diagnosis of Parkinson's disease
PLoS One. 2026 Jan 6;21(1):e0329980. doi: 10.1371/journal.pone.0329980. eCollection 2026.ABSTRACTBACKGROUND: Accurate diagnosis of Parkinson's Disease (PD) remains challenging due to its biological […]
- Brain cholinergic imaging in isolated REM sleep behavior disorder: Distinctions and similarities with Parkinson's disease
Parkinsonism Relat Disord. 2026 Jan 29;144:108226. doi: 10.1016/j.parkreldis.2026.108226. Online ahead of print.ABSTRACTBACKGROUND: Isolated rapid eye movement sleep behavior disorder (iRBD) is a […]
- Dual-Risk axis: GBA1 mutations and occupational pesticide exposure in Parkinson's disease
J Parkinsons Dis. 2026 Jan 19:1877718X251412233. doi: 10.1177/1877718X251412233. Online ahead of print.ABSTRACTBackgroundOccupational pesticide (OcP) exposure and pathogenic GBA1 variants are […]
- Consensus expert recommendations for management of dysphagia during hospital admission in Parkinson's disease
J Parkinsons Dis. 2026 Jan 5:1877718X251410503. doi: 10.1177/1877718X251410503. Online ahead of print.ABSTRACTDysphagia is a common and often underrecognized symptom in patients with Parkinson's […]
Traitements pharmacologiques
Médicaments
- Reducing delays in time-critical medications for Parkinson's disease: a multifaceted, multiprofessional quality improvement project
BMJ Open Qual. 2026 Jan 30;15(1):e003715. doi: 10.1136/bmjoq-2025-003715.ABSTRACTWhen people with Parkinson's disease (PD) are admitted to hospital, control of their symptoms can deteriorate, often […]
- Update on Medical Treatments for Essential Tremor: An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review
Mov Disord. 2026 Jan 20. doi: 10.1002/mds.70184. Online ahead of print.ABSTRACTBACKGROUND: The first International Parkinson and Movement Disorder Society Evidence-Based Medicine (MDS-EBM) review for […]
- Exploring the therapeutic potential of the gut microbiota metabolite 3-indolepropionic acid in parkinson's disease: a network pharmacology, molecular docking and cell viability study
Metab Brain Dis. 2026 Feb 5;41(1):28. doi: 10.1007/s11011-026-01794-z.ABSTRACTBackground the global burden of Parkinson's disease (PD) is rising, yet its pathogenesis remains incompletely understood. […]
- Micro pharmacokinetics-pharmacodynamics monitoring of anti-Parkinson's disease drugs using a microphysiological BBB-brain organ-on-a-chip
Microsyst Nanoeng. 2026 Feb 3;12(1):49. doi: 10.1038/s41378-025-01116-w.ABSTRACTEstablishing robust pharmacokinetics-pharmacodynamics (PK-PD) correlations remains a major challenge owing to high […]
- Ghrelin-based interventions in preclinical models of Parkinson's disease: a systematic review
Brain Res. 2026 Feb 3:150187. doi: 10.1016/j.brainres.2026.150187. Online ahead of print.ABSTRACTGhrelin plays a crucial role in metabolism and gastrointestinal function. In the central nervous […]
Études cliniques phase 3 et phase 4
- Targeting neuroinflammation in neurodegenerative disorders: the emerging potential of semaglutide
Inflamm Res. 2026 Jan 8;75(1):13. doi: 10.1007/s00011-025-02166-6.ABSTRACTBACKGROUND: Chronic neuroinflammation is increasingly recognized not as a secondary effect but as a primary driver of […]
- The road for developing new pharmacological therapies for Parkinson's disease: Current trends and targets in clinical trials
J Parkinsons Dis. 2026 Jan 16:1877718X251412671. doi: 10.1177/1877718X251412671. Online ahead of print.ABSTRACTBackgroundDespite substantial research efforts, advances in Parkinson's disease […]
- Prospective Randomized Controlled Trial of the Impact of Olfactory Training on Cognitive and Emotional Function in Individuals with Parkinson Disease
Arch Rehabil Res Clin Transl. 2025 Jul 24;7(4):100497. doi: 10.1016/j.arrct.2025.100497. eCollection 2025 Dec.ABSTRACTOBJECTIVE: To investigate the clinical effects of olfactory training (OT) on […]
- Foslevodopa/Foscarbidopa in Younger Patients Earlier Within Advanced Parkinson's Disease: Post Hoc Analysis of a Randomized Trial
Neurol Ther. 2025 Dec 1. doi: 10.1007/s40120-025-00856-1. Online ahead of print.ABSTRACTINTRODUCTION: We evaluated continuous subcutaneously administered foslevodopa/foscarbidopa (LDp/CDp) in younger […]
- Advances in Neurological Therapies: A Review of Clinical Trials in Alzheimer's, Parkinson's, and Multiple Sclerosis
Am J Med. 2025 Nov 27:S0002-9343(25)00826-5. doi: 10.1016/j.amjmed.2025.11.025. Online ahead of print.ABSTRACTThe period from 2020 to 2025 marked a pivotal juncture in the treatment of major […]
Traitements non pharmacologiques
Chirurgie
- Effectiveness of noninvasive brain stimulation for patients with central poststroke pain: a systematic review and meta analysis of randomized controlled trials
Am J Phys Med Rehabil. 2025 Dec 29. doi: 10.1097/PHM.0000000000002924. Online ahead of print.ABSTRACTOBJECTIVE: To systematically evaluate the effects of noninvasive brain stimulation (NIBS) on pain […]
- Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines (2017-2025: An update) - endorsed by the European Society for Brain Stimulation (ESBS) and by the International Federation for Clinical Neurophysiology (IFCN)
Clin Neurophysiol. 2025 Nov 23:2111436. doi: 10.1016/j.clinph.2025.2111436. Online ahead of print.ABSTRACTThis guideline summarizes updated safety data (2017-2025) and provides expert recommendations […]
- Clinical utility of evoked potentials for programming subthalamic deep brain stimulation in Parkinsons disease
NPJ Parkinsons Dis. 2026 Jan 23. doi: 10.1038/s41531-026-01274-2. Online ahead of print.ABSTRACTOptimal subthalamic nucleus deep-brain stimulation (STN-DBS) for Parkinson's disease reduces motor […]
- Preoperative Brain Atrophy as a Predictor of Motor Outcomes After STN Deep Brain Stimulation in Parkinson's Disease
Stereotact Funct Neurosurg. 2026 Jan 23:1-29. doi: 10.1159/000549635. Online ahead of print.ABSTRACTBackground Brain atrophy is common in Parkinson's disease (PD) and contributes to motor and […]
- Can transcranial Direct Current Stimulation enhance the efficacy of a rehabilitative intervention for the treatment of Freezing of Gait in Parkinson's disease? A double-blind, randomized controlled study
J Parkinsons Dis. 2026 Feb 4:1877718X261416181. doi: 10.1177/1877718X261416181. Online ahead of print.ABSTRACTBackgroundFreezing of gait (FOG) in Parkinson's disease (PD) is a major cause of […]
Approches multidisciplinaires
- Home-Based time-constrained reactive training enhances movement speed in upper and lower limbs in Parkinson's disease: A randomized controlled trial
J Parkinsons Dis. 2026 Jan 30:1877718X251405813. doi: 10.1177/1877718X251405813. Online ahead of print.ABSTRACTBradykinesia and delayed step initiation are central features of Parkinson's disease […]
- Research Progress of Natural Components Improving Parkinson's Disease by Regulating the Oxidative Stress
Phytother Res. 2026 Feb 1. doi: 10.1002/ptr.70214. Online ahead of print.ABSTRACTParkinson's disease (PD), the second most prevalent neurodegenerative disorder globally, places a considerable burden […]
- Physiotherapist-led community gymnasium exercises for individuals with early onset Parkinson's: a qualitative analysis
Disabil Rehabil. 2026 Feb 1:1-13. doi: 10.1080/09638288.2025.2606644. Online ahead of print.ABSTRACTPURPOSE: With the increasing prevalence of early onset Parkinson's disease (EOPD) world-wide, there […]
- Exploring Dynamic Alpha Band Connectivity in Parkinson's Disease: A Novel Approach to Postural Control Assessment Using the BioVRSea Paradigm
Brain Topogr. 2026 Feb 2;39(2):20. doi: 10.1007/s10548-025-01170-7.ABSTRACTParkinson's Disease (PD) is a neurological disorder characterized by impaired postural control (PC) and balance issues. To […]
- Comparative Efficacy of 17 Rehabilitation Therapies Combined with Medication for Improving Gait Disorders and quality of life in Parkinson's Disease: A Network Meta-Analysis of 137 RCTs
Arch Phys Med Rehabil. 2026 Jan 14:S0003-9993(26)00021-3. doi: 10.1016/j.apmr.2026.01.002. Online ahead of print.ABSTRACTOBJECTIVE: This network meta-analysis aimed to systematically compare the […]
Thérapies alternatives
- Parkinson's disease and voluntary walking interventions - a systematic review and meta-analysis
Arch Phys Med Rehabil. 2026 Jan 31:S0003-9993(26)00048-1. doi: 10.1016/j.apmr.2026.01.024. Online ahead of print.ABSTRACTOBJECTIVE: The primary objective was to quantify the effect of interventions […]
- Unraveling the metabolic potential of Moringa oleifera derived metabolites in combating Parkinson's and Alzheimer's disease
Bioorg Chem. 2026 Feb;169:109442. doi: 10.1016/j.bioorg.2025.109442. Epub 2025 Dec 27.ABSTRACTMoringa oleifera is a nutrient-rich medicinal plant recognized for its broad-spectrum therapeutic […]
- A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease
J Parkinsons Dis. 2026 Feb 4:1877718X261418986. doi: 10.1177/1877718X261418986. Online ahead of print.ABSTRACTBackgroundBoth Mediterranean and ketogenic diets have been proposed as nutritional […]
- Feasibility and potential effectiveness of an exergame program for people with moderate to advanced Parkinson's disease: A pilot randomized controlled trial
J Parkinsons Dis. 2026 Feb 4:1877718X261418989. doi: 10.1177/1877718X261418989. Online ahead of print.ABSTRACTBackgroundExergaming has shown benefits in Parkinson's disease (PD) rehabilitation; […]
- Cardiovascular exercise enhances motor learning across multiple sessions in people with Parkinson's disease: a randomized controlled pilot trial
NPJ Sci Learn. 2025 Dec 23. doi: 10.1038/s41539-025-00391-6. Online ahead of print.ABSTRACTMotor learning is critical for effective motor rehabilitation, yet impaired in people with Parkinson's […]
Qualité de vie des patients
Expérience patient
- Defining Quality of Life: The Perspective of People Living with Parkinson's Disease
Mov Disord Clin Pract. 2026 Jan 10. doi: 10.1002/mdc3.70517. Online ahead of print.ABSTRACTBACKGROUND: Little is known about how people with Parkinson's conceptualize "quality of life."OBJECTIVE: To […]
- EMPOWER-PD: Evaluation of an 8-Week Co-Designed Self-Management Program in People With Parkinson's Disease and Their Caregivers: An Intervention Study With Long-Term Follow-Up
Parkinsons Dis. 2025 Dec 6;2025:9413261. doi: 10.1155/padi/9413261. eCollection 2025.ABSTRACTEmpowerment and implementation of self-management strategies are vital components in the future care of […]
- Home-based exercise rehabilitation experience for older adult patients with Parkinson's disease and caregivers: a qualitative research
Front Public Health. 2025 Dec 22;13:1735475. doi: 10.3389/fpubh.2025.1735475. eCollection 2025.ABSTRACTOBJECTIVE: To understand the real-life experiences and needs of older adult patients with […]
- Camaraderie for Care Partners: Addressing the Well-Being of Care Partners for Singing Group Participants With Parkinson's Disease Through a Phenomenological Qualitative Approach
Dementia (London). 2026 Jan 23:14713012261418734. doi: 10.1177/14713012261418734. Online ahead of print.ABSTRACTCare partners of individuals with Parkinson's disease experience challenges while […]
- Sexual dysfunction in Parkinson's disease: what about women?
J Neurol Sci. 2026 Jan 16;481:125757. doi: 10.1016/j.jns.2026.125757. Online ahead of print.ABSTRACTBACKGROUND: Sexual dysfunction is a common and distressing non-motor symptom in Parkinson's Disease […]
- Effects of Combined Psychological and Functional Exercise Interventions on Emotion, Life Quality, and Brain-Derived Neurotrophic Factor Levels in Patients With Parkinson's Disease: A Randomized Controlled Trial
Int J Psychiatry Med. 2026 Jan 29:912174261422307. doi: 10.1177/00912174261422307. Online ahead of print.ABSTRACTObjectiveTo evaluate the effects of a combined psychological and functional exercise […]
- Does Adding Real-Time Postural Feedback During Training Boost Balance and Mobility in Individuals With Parkinson's Disease? A Systematic Review and Meta-Analysis
J Appl Gerontol. 2026 Jan 29:7334648261419637. doi: 10.1177/07334648261419637. Online ahead of print.ABSTRACTObjectiveTo evaluate the specific contribution of the real-time postural feedback […]
- Patient and Physician Perspectives on Pharmacotherapy in Parkinson's Disease Psychosis: A Mixed-Methods Exploratory Study
Pharmacy (Basel). 2026 Jan 13;14(1):8. doi: 10.3390/pharmacy14010008.ABSTRACTPsychosis is a frequent and disabling non-motor complication of Parkinson's disease (PD). Clozapine and quetiapine are […]
Technologies de soutien
- Parkinson's disease gait rehabilitation at scale: Insights on personalised smartphone-based music cueing
PLoS One. 2026 Jan 5;21(1):e0340106. doi: 10.1371/journal.pone.0340106. eCollection 2026.ABSTRACTThis study investigates the perceptions of people with Parkinson's Disease (PwPD) regarding the use of […]
- Telerehabilitation for the treatment of nocturnal hypokinesia in people with Parkinson's disease: a pilot study
Neurol Sci. 2026 Jan 17;47(1):174. doi: 10.1007/s10072-025-08594-w.ABSTRACTINTRODUCTION: Nocturnal hypokinesia (NH) (i.e., reduced bed mobility) is common in people with Parkinson's Disease (PwPD), […]
- Effects of Telehealth Interventions for People With Parkinson Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials
JMIR Mhealth Uhealth. 2026 Jan 28;14:e70994. doi: 10.2196/70994.ABSTRACTBACKGROUND: The global integration of telehealth into the management of Parkinson disease (PD) addresses critical gaps in […]
- Immersive virtual reality upper-limb exercises in people with Parkinson's disease: an observer-blinded randomised controlled trial
J Neuroeng Rehabil. 2026 Jan 8;23(1):9. doi: 10.1186/s12984-025-01851-1.NO ABSTRACTPMID:41508050 | DOI:10.1186/s12984-025-01851-1
- Home-Based Augmented Reality Gait-and-Balance Therapy in Parkinson's Disease: An examination of exercise intensity
Arch Phys Med Rehabil. 2025 Dec 29:S0003-9993(25)01121-9. doi: 10.1016/j.apmr.2025.12.008. Online ahead of print.ABSTRACTOBJECTIVE: Our objectives to examine whether Strolll - an […]
Associations et ordres professionnels
Québec
- Conférence | Parkinson : de l’aide pour vouson 6 mars 2026
La Bibliothèque du CHUM vous propose une conférence pour découvrir les nombreux services offerts par Parkinson Québec. Cet organisme soutient les personnes atteintes de la maladie de Parkinson et […]
- Aide médicale à mourir : comprendre les critères et les démarches (2026)on 6 février 2026
🎥 La rediffusion de notre dernier webinaire est disponible ! Vous n'avez pas pu assister au live ou vous souhaitez revoir les meilleurs moments ? Bonne nouvelle : la vidéo complète est […]
- 📣 Participants recherchés – Étude de recherche à l’Université Concordiaon 6 février 2026
📣 Participants recherchés – Étude de recherche à l’Université Concordia Vous vivez avec la maladie de Parkinson et présentez des tremblements au bras ou à la main? Une équipe de […]
- L’inscription pour les sessions d’hiver 2026 du projet Imagerie diagnostique est ouvert !on 6 février 2026
L’inscription pour les sessions d’hiver 2026 du projet Imagerie diagnostique est ouvert ! Le projet Imagerie diagnostique propose de réunir des personnes atteintes de la maladie de Parkinson et […]
- 📣 Appel de candidatures – Conseil d’administration de Parkinson Québecon 6 février 2026
📣 Appel de candidatures – Conseil d’administration de Parkinson Québec Parkinson Québec lance un appel de candidatures afin de pourvoir des postes d’administratrices et […]
- Revivez le Défi Trek Parkinson 2025… et préparez-vous pour la deuxième édition en 2026on 6 février 2026
Envie de ressentir l’esprit du Défi Trek? Revivez les moments forts de l’édition 2025 à travers notre vidéo récapitulative. Des défis relevés, des émotions vraies, des sourires, de la […]
- 🌳 Pour une deuxième année consécutive, le Défi Vélo Parkinson vous donne rendez-vous au Parc régional éducatif bois de Belle-Riv...on 6 février 2026
🌳 Pour une deuxième année consécutive, le Défi Vélo Parkinson vous donne rendez-vous au Parc régional éducatif bois de Belle-Rivière à Mirabel. Un site magnifique, sécuritaire et […]
Canada
- A newly updated resource for care partnerson 6 mars 2026
Care Partnering: Managing Parkinson¿s together, is available now View this email in your browser Care partners need support, too. […]
- Parkinson Canada s’associe à CurePSPon 6 février 2026
Date d'affichage : 29 janv. 2026 Parkinson Canada est fière d’annoncer un nouveau partenariat passionnant avec CurePSP, la principale organisation à but non lucratif dédiée à la […]
- Community events and webinars - Parkinson Canadaon 6 février 2026
Skip to content Join us for engaging events and webinars designed to inform, support, and connect the Parkinson’s community. Community events offer a welcoming space to meet others who […]
- Ressources et guides pour bien démarrer l’année 2026on 6 février 2026
Skip to content Date d'affichage : 12 janv. 2026 Au début d’une nouvelle année, nous pensons à tourner une nouvelle page. Cela signifie prendre des résolutions, faire des plans et […]
- Les partenaires de soins comptenton 6 février 2026
Date d'affichage : 2 févr. 2026 Les ressources nouvellement mises à jour de Parkinson Canada pour les partenaires de soins sont maintenant disponibles. Le partenariat de soins : gérer la maladie […]
- Les liens qui me portent – L’histoire de Jacques Séguinon 6 février 2026
Je m’appelle Jacques Seguin. Je suis un mari, un père de quatre filles incroyables et un grand-père fier de sept petits-enfants. J’ai passé une grande partie de ma vie dans le domaine de […]
- Share your Parkinson's care experienceon 6 février 2026
Have your voice be heard and change the future of health care for people with Parkinson¿s. View this email in your browser Hello […]
- Managing your medications just got easieron 6 février 2026
Check out this new guide to help manage your medications View this email in your browser Managing your medications Starting a new […]
États-Unis
- The benefits of pets for those of us with Parkinson’s diseaseon 6 février 2026
During the time in my life when I was busy and always rushing around, with no idea what Parkinson’s disease even was, my husband, John, and I “peaked” on pets: 12 chickens, five cats, two […]
- Environmental factors may impact Parkinson’s disease risk: Dutch studyon 6 février 2026
In the Netherlands, new cases of Parkinson’s disease occur more often in men, older adults, people with higher socioeconomic status, and residents of the northern provinces, suggesting that […]
- Gut immune cells may help Parkinson’s spread from the belly to the brainon 6 février 2026
Parkinson’s disease may actually begin deep in the gut, where immune cells meant to protect the body inadvertently help toxic proteins make their way to the brain, according to a new study. […]
- Lessons revealed in the quiet moments of Parkinson’s caregivingon 6 février 2026
The drive home turned into a quiet ceremony, a gentle transition between worlds I didn’t yet have the language for. After spending long days with my uncle Brandon, who had Parkinson’s disease, I […]
- Lifestyle Strategies to Boost Brain Healthon 6 février 2026
No matter your age, whether you have Parkinson’s or not, there are steps you can take today to boost your brain health. 🧠 In a new podcast episode, movement disorder specialist, life medicine […]
- EPA Reassess Paraquaton 6 février 2026
Lawmakers need to hear from people impacted by paraquat — a pesticide linked to Parkinson’s disease. The federal government is paying attention, following a recent post from EPA Administrator […]
- What can researchers from Parkinson’s and Alzheimer’s learn from each other?on 6 février 2026
What can researchers from Parkinson’s and Alzheimer’s learn from each other? Scientists are discovering how different diseases affect the brain in ways that overlap. Understanding this […]
- Stress and Parkinson’s: Strategies to Manage the Strain (Webinar Audio)on 6 février 2026
Experiencing some stress is a normal part of life, but many people living with Parkinson's notice stress may worsen symptoms and make medication less effective. And chronic stress can cause lasting […]
- A New Link Between Air Pollution and Dementiaon 6 février 2026
A New Link Between Air Pollution and Dementia A major scientific study has uncovered compelling evidence that air pollution may directly increase the risk of Lewy body dementia (LBD), a group […]
- The Relationship Between Pesticides and Parkinson’son 6 février 2026
What We Know About the Link Between Pesticides and PD Just like every chronic disease, the risk of developing Parkinson’s disease is due to a combination of genetic and environmental […]
International
- New Parkinson’s project aims to fill knowledge gap about disease-modifying therapieson 6 février 2026
“Many people with Parkinson’s are not familiar with the term ‘disease-modifying therapy’ and have not heard of it previously,” says Kate Trenam, Head of Patient Engagement (Neurosciences) […]
- Parkinson’s diet and brain function: what is a superfood for Parkinson’s disease?on 6 février 2026
Wondering what kind of foods can help improve brain health and overall wellness for neurological conditions like Parkinson’s? Despite the buzz around the phrase ‘superfoods’, there is no single […]
- Foods to avoid with Parkinson’s disease – dietitian-approved advice on what foods to limit and whyon 5 janvier 2026
Although diet and nutrition are well-known to be important when it comes to living well with Parkinson’s, it can tricky to work out what foods to avoid with Parkinson’s, or simply limit, and […]
- Foot exercises for Parkinson’s to do at homeon 5 janvier 2026
What are the best foot exercises for people with Parkinson’s? If you’re living with Parkinson’s, everything from a change in gait or balance problems to increasing stiffness can have an effect […]
- Global Alliance for Parkinson’s Platforms (GAPP) unites global trials leaderson 5 janvier 2026
UK-based organisation Cure Parkinson’s has united with France Parkinson to form new platform trials organisation Global Alliance for Parkinson’s Platforms (GAPP), it announced in November. GAPP […]
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


